Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
Open Access
- 7 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (12) , 2290-2297
Abstract
Objectives. SSc (scleroderma) is an often fatal disease characterized by widespread tissue fibrosis. Fibroblasts play a key role in SSc-associated fibrosis. This study was designed to determine: (i) whether fibroblasts isolated from skin of patients with SSc have increased lysophosphatidic acid-activated Cl− current (IClLPA) activity vs healthy controls; (ii) whether myofibroblast differentiation is involved in SSc skin fibrosis; and (iii) whether SSc fibroblasts have different proliferation rates vs controls. Methods. Skin biopsies were taken from involved and uninvolved skin of SSc patients and controls. Whole-cell perforated patch-clamping was used to measure IClLPA activity in fibroblasts isolated and cultured from these biopsies. Western blotting was used to measure α-smooth muscle actin (α-SMA). Proliferation was measured using a colorimetric assay. Results. Fibroblasts cultured from SSc skin show significantly increased IClLPA activity following LPA exposure compared with control skin fibroblasts. α-SMA protein was significantly increased in cultured SSc skin fibroblasts vs controls. No significant differences in proliferation rates were found. Conclusions. Elevated IClLPA activity is a hallmark of SSc skin fibroblasts. Blocking IClLPA activation may be a new therapeutic approach for treating SSc-associated fibrosis.Keywords
This publication has 42 references indexed in Scilit:
- LPA1 Receptor Activation Promotes Renal Interstitial FibrosisJournal of the American Society of Nephrology, 2007
- Lysophosphatidic Acid Interacts with Transforming Growth Factor-β Signaling to Mediate Keratinocyte Growth Arrest and ChemotaxisJournal of Investigative Dermatology, 2004
- Cytokine regulation of pulmonary fibrosis in sclerodermaCytokine & Growth Factor Reviews, 2003
- Fibroblast and endothelial apoptosis in systemic sclerosisCurrent Opinion in Rheumatology, 2003
- The myofibroblast in wound healing and fibrocontractive diseasesThe Journal of Pathology, 2003
- Platelet-Derived Growth Factor-BB and Lysophosphatidic Acid Distinctly Regulate Hepatic Myofibroblast Migration through Focal Adhesion KinaseExperimental Cell Research, 2002
- Receptor-mediated activation of a Cl(-) current by LPA and S1P in cultured corneal keratocytes.2002
- Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: The importance of concomitant arterial and venous diseaseJournal of Vascular Surgery, 2000
- Dermal mast cell degranulation in systemic sclerosisArthritis & Rheumatism, 1990
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980